HHS Issues Draft Guidance For Next Round of Drug Price Talks (2)

The Biden administration Friday rolled out its draft guidance for the next cycle of drug price negotiations, spurring pushback from the pharmaceutical industry.

The guidance lays out the Centers for Medicare & Medicaid Services’ requirements and parameters for the second cycle of negotiations in the Medicare Drug Price Negotiation Program.

Fifteen Medicare Part D drugs will be selected for the second negotiation round. The agency is expected to announce the list of Medicare Part D drugs no later than Feb. 1, 2025. Those agreed to negotiated prices will go into effect in 2027.

The plan, considered one of President Joe ...